Dr. James Moon is John Gideon Searle Associate Professor in the Department of Pharmaceutical Sciences and Biomedical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. His innovative research has led to a new class of vaccine nanoparticle system that can elicit unprecedented levels of T- and B-cell immune responses. Dr. Moon has published over 90 research articles, including those published in Nature Materials, Nature Medicine, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has 16 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to two new start-up companies, Vedantra Pharmaceuticals and EVOQ Therapeutics. Dr. Moon contribution to the field has been recognized with numerous awards, including AAPS Emerging Leader Award, NSF CAREER Award, and DOD-CDMRP Career Development Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley, and his Ph.D. from Rice University, and he completed his postdoctoral training at MIT.